title: Regenerative medicine in China: main progress in different fields.
abstract: Regenerative medicine (RM) is an emerging interdisciplinary field of research and China has developed the research quickly and impressed the world with numerous research findings in stem cells, tissue engineering, active molecules and gene therapy. Important directions are induced differentiation of induced pluripotent stem and embryo stem cells as well as somatic stem cell differentiation potential and their application in trauma, burns, diseases of aging and nerve regeneration. The products ActivSkin and bone repair scaffolds have been approved and are applied in the clinic, and similar products are being studied. About 10 engineered growth-factor drugs for repair and regeneration have been approved and are used in the clinic. Gene therapy, therapeutic cloning and xenotransplantation are some of the strategies being studied. However, China needs to develop standards, regulations and management practices suitable for the healthy development of RM. Aspects that should be strengthened include sound administrative systems, laws, and technical specifications and guidelines; conservation of stem cell resources; emphasis on training and retention of talented stem cell researchers; and reasonable allocation of resources, diversification of investment and breakthroughs in key areas. Finally, broad and deep international cooperation is necessary.
authors.affiliation: Medical College of PLA, General Hospital of PLA, College of Life Sciences, Beijing, 100853 China ; The Key Laboratory of Trauma Treatment & Tissue Repair of Tropical Area of PLA, Guangzhou, 510010 China.
authors.forename: Biao
authors.initials: B
authors.lastname: Cheng
authors.affiliation: Shanghai Burns Institute, Ruijing Hospital, Shanghai Jiaotong University, Shanghai, 200025 China.
authors.forename: Shu-Liang
authors.initials: SL
authors.lastname: Lu
authors.affiliation: Medical College of PLA, General Hospital of PLA, College of Life Sciences, Beijing, 100853 China.
authors.forename: Xiao-Bing
authors.initials: XB
authors.lastname: Fu
keywords: China; Regenerative medicine; Stem cells; Tissue engineering